Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infection

被引:32
作者
Zhang, Zhi-Qiang [1 ]
Casimiro, Danilo R.
Schleif, William A.
Chen, Minchun
Citron, Michael
Davies, Mary-Ellen
Burns, Janine
Liang, Xiaoping
Fu, Tong-Ming
Handt, Larry
Emini, Emilio A.
Shiver, John W.
机构
[1] Merck Res Labs, Dept Vaccines & Biol Res, West Point, PA 19486 USA
[2] Wyeth Pharmaceut, Collegeville, PA 19426 USA
关键词
SIVmac239; rapid progression; lymph node; proliferating B cells; germinal center; immunohistochemistry; in situ hybridization;
D O I
10.1016/j.virol.2006.12.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Lack of virus specific antibody response is commonly observed in both HIV-1-infected humans and SIV-infected monkeys with rapid disease progression. However, the mechanisms underlying this important observation still remain unclear. In a titration study of a SIVmac239 viral stock, three out of six animals with viral inoculation rapidly progressed to AIDS within 5 months. Unexpectedly, there was no obvious depletion of CD4(+) T cells in both peripheral and lymph node (LN) compartments in these animals. Instead, progressive depletion of proliferating B cells and disruption of the follicular dendritic cell (FDC) network in germinal centers (GC) was evident in the samples collected at as early as 20 days after viral challenge. This coincided with undetectable, or weak and transient, virus-specific antibody responses over the course of infection. In situ hybridization of SIV RNA in the LN samples revealed a high frequency of SIV productively infected cells and large amounts of accumulated viral RNA in the GCs in these animals. Early severe depletion of GC proliferating B cells and disruption of the FDC network may thus result in an inability to mount a virus-specific antibody response in rapid progressors, which has been shown to contribute to accelerated disease progression of SIV infection. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:455 / 464
页数:10
相关论文
共 37 条
[1]   Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection [J].
Baba, TW ;
Liska, V ;
Hofmann-Lehmann, R ;
Vlasak, J ;
Xu, WD ;
Ayehunie, S ;
Cavacini, LA ;
Posner, MR ;
Katinger, H ;
Stiegler, G ;
Bernacky, BJ ;
Rizvi, TA ;
Schmidt, R ;
Hill, LR ;
Keeling, ME ;
Lu, YC ;
Wright, JE ;
Chou, TC ;
Ruprecht, RM .
NATURE MEDICINE, 2000, 6 (02) :200-206
[2]   Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag [J].
Casimiro, DR ;
Wang, FB ;
Schleif, WA ;
Liang, XP ;
Zhang, ZQ ;
Tobery, TW ;
Davies, ME ;
McDermott, AB ;
O'Connor, DH ;
Fridman, A ;
Bagchi, A ;
Tussey, LG ;
Bett, AJ ;
Finnefrock, AC ;
Fu, TM ;
Tang, AM ;
Wilson, KA ;
Chen, MC ;
Perry, HC ;
Heidecker, GJ ;
Freed, DC ;
Carella, A ;
Punt, KS ;
Sykes, KJ ;
Huang, LY ;
Ausensi, VI ;
Bachinsky, M ;
Sadasivan-Nair, U ;
Watkins, DI ;
Emini, EA ;
Shiver, JW .
JOURNAL OF VIROLOGY, 2005, 79 (24) :15547-15555
[3]   Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression [J].
Dykhuizen, M ;
Mitchen, JL ;
Montefiori, DC ;
Thomson, J ;
Acker, L ;
Lardy, H ;
Pauza, CD .
JOURNAL OF GENERAL VIROLOGY, 1998, 79 :2461-2467
[4]   MASSIVE COVERT INFECTION OF HELPER T-LYMPHOCYTES AND MACROPHAGES BY HIV DURING THE INCUBATION PERIOD OF AIDS [J].
EMBRETSON, J ;
ZUPANCIC, M ;
RIBAS, JL ;
BURKE, A ;
RACZ, P ;
TENNERRACZ, K ;
HAASE, AT .
NATURE, 1993, 362 (6418) :359-362
[5]   MULTIFACTORIAL NATURE OF HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - IMPLICATIONS FOR THERAPY [J].
FAUCI, AS .
SCIENCE, 1993, 262 (5136) :1011-1018
[6]   Host factors and the pathogenesis of HIV-induced disease [J].
Fauci, AS .
NATURE, 1996, 384 (6609) :529-534
[7]   Changing the natural history of HIV disease [J].
Feinberg, MB .
LANCET, 1996, 348 (9022) :239-246
[8]   Quantitative image analysis of HIV-1 infection in lymphoid tissue [J].
Haase, AT ;
Henry, K ;
Zupancic, M ;
Sedgewick, G ;
Faust, RA ;
Melroe, H ;
Cavert, W ;
Gebhard, K ;
Staskus, K ;
Zhang, ZQ ;
Dailey, PJ ;
Balfour, HH ;
Erice, A ;
Perelson, AS .
SCIENCE, 1996, 274 (5289) :985-989
[9]   Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies [J].
Haigwood, NL ;
Montefiori, DC ;
Sutton, WF ;
McClure, J ;
Watson, AJ ;
Voss, G ;
Hirsch, VM ;
Richardson, BA ;
Letvin, NL ;
Hu, SL ;
Johnson, PR .
JOURNAL OF VIROLOGY, 2004, 78 (11) :5983-5995
[10]   Passive immune globulin therapy in the SIV/macaque model: Early intervention can alter disease profile [J].
Haigwood, NL ;
Watson, A ;
Sutton, WF ;
McClure, J ;
Lewis, A ;
Ranchalis, J ;
Travis, B ;
Voss, G ;
Letvin, NL ;
Hu, SL ;
Hirsch, VM ;
Johnson, PR .
IMMUNOLOGY LETTERS, 1996, 51 (1-2) :107-114